文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > Serratiopeptidase A systematic review of the existing evidence
侵权投诉

Serratiopeptidase A systematic review of the existing evidence

S.Bhagatetal./InternationalJournalofSurgery11(2013)209e217

211

3.Evidencesynthesis

SearchonCochraneLibrarydatabaseusingkeyword‘Serratio-peptidase’revealed16resultsamongwhich8wereRCTsrelatedtoef cacyofSerratiopeptidase.Arepeatedsearchonthesamedata-baseusingkeyword‘Serrapeptase’revealed9resultsamongwhich6wereRCTs.Therefore,atotalof11RCTswereincludedinourreviewexcludingthosewhichwereduplicatedandwherefulltextwasnotavailable.

PubMedsearchusingkeywords‘Serratiopeptidase’or‘Serra-peptase’revealed74resultswhichshowed16clinicaltrialsoutofwhich9wereRCTsrelatedtoef cacyofSerratiopeptidase.Thus,atotalof14RCTswereincludedinourreview.Onlythosestudieswereincludedwhichwerepublishedandwherefulltextwasavailableexcludingthosewithduplicateresults.Variouspublishedstudieshavere ectedtheuseofSerratiopeptidaseforitsanti-in ammatory,anti-edemicandanalgesiceffects.Someanecdotalstudiessuggestittopossessanti-atheroscleroticeffectsalso.

Therewere6clinicalstudies(Table1)supportingtheanti-in ammatoryeffectsofSerratiopeptidase.Butamongtheseclini-caltrialsthedoseanddurationoftherapywasnotspeci edin2ofthesestudiesandwerehavingsmallsamplesize,3wereplacebo-controlledtrials,while1studywithactivecomparatorSeaproseS(SAP)hadshownSeaproseStobebetterthanSerratiopeptidase.Therewere3studiesindentalpatientstoseethepostoperativeanti-in ammatoryeffectsofSerratiopeptidase(Table1).

InonestudybyKhateebetal.,24SerratiopeptidaseþParacetamolcombinationwascomparedtoPlaceboþParacetamolinpatientsaftersurgicalremovalofimpactedthirdmolars.ItwasconcludedthatSerratiopeptidaseþparacetamolgroupshowedsigni cantreductioninextentofcheekswellingandpain,buttherewasnodifferenceinmeanmaximalinterincisaldistancebetweenthetwogroups.SimilarstudybyChopraetal.25comparingSerratiopeptidasewithibuprofen/betamethasone/paracetamol/placeboshowedser-ratiopeptidasegrouptohavelessmeanpainscoresandswellingascomparedtoplacebobutthedifferencewasnotstatisticallysigni -cant.Moreover,serratiopeptidasewasnotsuperiorwhencomparedtoibuprofenandbetamethasone.ThethirdstudybySurachaietal.26inpatientswithpostoperativeswellingafterremovalofimpactedmolarsdidnotshowanysigni cantdifferenceindegreeoffacialswellingintheSerratiopeptidaseandnomedicationgroups.Itwasatrialwithsmallsamplesizeandstudydesignnotmentioned.

Further5studiesindifferentotorhinolaryngologypathol-ogies1,16e20havetriedtoexplorethemucolyticpropertiesofser-ratiopeptidase.Twowereplacebo-controlledtrials,amongwhichonestudy1showedSerratiopeptidasereducedthesymptomsofseverityofpain,amountandpurulenceofsecretionsbutinthesecondstudy16outcomeswereunclear.Anotherprospective,openlabelstudy19showedSerratiopeptidasetoreducetheviscositybutnottheelasticityofsecretionsinpatientsofchronicsinusitis.Similarly,onestudy20inchronicairwaydiseasepatientscomparedSerratiopeptidasewithnon-treatmentgroupandconcludedittoreducesputumviscosity,elasticityandneutrophilcount.Therewasonlyonestudy17inchronicrespiratorydiseasepatientswithdif- cultyinexpectoration,whereSerratiopeptidasewascomparedwithanactivecomparatorSeaproseSandthisstudyshowedSeaproseStobebetterthanSerratiopeptidaseinrelievingdif cultyinexpectorationandspeci csymptoms.

Insomestudies21e23theroleofSerratiopeptidaseinincreasingtheeffectiveconcentrationofantimicrobialsindifferenttissueswasstudied.TheseshowedthatSerratiopeptidaseincreasedtheconcentrationofantimicrobialsintissues.Butamongthesestudies,onewasprospectiveopenlabeltrial.21Oneofthestudies22didnotmentionthedurationoftherapyandotherwasarandomised,openlabeltrialinwhichSerratiopeptidaseþcefotiamwasadministered

forprophylaxisbeforesurgery,butagaindurationoftreatmentwasnotgiven.

Bandolier27onlineedition(retrievedon1/5/2011)showedare-view“Serratiopeptidase- ndingtheevidence”.Thisreviewcon-cludedthattherewerenotrialsofSerratiopeptidasefortreatmentofbackpain,neithertherewereanytrialsforitsuseinheartattackandstroke.Amongthe9RCTsincludedinthisreviewwhichweregen-erallysaidtobeofpoormethodologicalquality, vestudiesweredescribedasdouble-blind:onewascompletelyun-interpretable,threemethodologicallyweakstudieswerepositiveandonetrialofapparenthighqualitywasnegative.

3.1.Evidencefromclinicalandpreclinicalstudies

Atotalof24studiesonef cacyofSerratiopeptidasewereincludedwhichmettheinclusioncriteria.Amongthese18wereclinicaland6werepreclinicalstudies(Tables1and2).3.2.Clinicalevidence

SerratiopeptidasehasbeenusedinSurgery(Traumaticandpostoperativein ammation,4,14venousin ammatorydisease,15cystitis,epididymitis34),Orthopaedics(Traumaticswellingaftersportsinjury,4carpaltunnelsyndrome,7osteoarticularinfectiontoincreaseantibioticconcentrationatinfectionsite21),Otolaryngology(Sinusitis,rhinitis,laryngitis,bronchitis,inadequateexpectorationofsputuminbronchialasthma1,19,20),Gynaecology(Engorgementofbreasts5,35),Dentistry(Anti-in ammatoryandtoincreaseantibioticconcentrationatsiteofinfectioninperiodontitis,36pericoronitisofwisdomtooth25).

TheevidencefromclinicalstudieshasbeengradedaccordingtothechecklistgivenbytheScottishIntercollegiateGuidelinesNet-work(SIGN).12Thegradingshowedthatthestudiessupportingtheanti-in ammatoryandanalgesicroleofSerratiopeptidasearegenerallyofpoormethodology.Firstlythenumberofstudiesareonlyfew.Secondly,thestudieswhicharethere,eitherhaveasmallsamplesize(notmorethan150patientspergroupinanyofthestudies)orareofshortduration.Moreover,thestudiesaremostlyplacebo-controlledtrialsandlackanactivecomparator.Alsotheeligibilitycriteriaandoutcomevariablesarenotwellde nedand nallythestatisticalmethodsusedforanalysingthesigni cancelevelhavenotbeenexplained(Table1).3.3.Studiesinanimals

Thestudiesinanimalsareveryfew.Thesehaveonlydemon-stratedtheanti-in ammatoryeffectsofSerratiopeptidase.Nospeci cmodelhasbeenusedinanyofthesestudiestoscreenfortheanalgesicandanti-atheroscleroticeffectsofthisenzymeinparticular(Table2).In3animalstudies28e30Serratiopeptidasewasshowntoincreasetheantimicrobialconcentrationatthesiteofinfection.Whilein2studies32,33usinganti-in ammatoryanimalmodelsitwasshownthatSerratiopeptidasedemonstratedsigni -cantanti-in ammatoryactivitywhencomparedtochymotrypsin,trypsin,aspirinanddiclofenac.Inanotherstudy,31whereSerra-tiopeptidasewascomparedtoactivecomparatorseaprose.Bothenzymesshowedreductioninviscosityofsputum,butthedurationoftherapywasnotmentioned.4.Source

Serratiopeptidaseisderivedfromnon-pathogenicenter-obacteriabelongingtogenusSerratiaspeciesE-15.Thismicro-organismwasoriginallyisolatedduringlate1960sfromtheintestinesofsilkwormBombyxmoriwhichisitsnaturalhabitat.

上一页第3页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email